Biodesix Statistics
Share Statistics
Biodesix has 146.56M
shares outstanding. The number of shares has increased by 27.28%
in one year.
Shares Outstanding | 146.56M |
Shares Change (YoY) | 27.28% |
Shares Change (QoQ) | 0.35% |
Owned by Institutions (%) | 40.09% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 1,000 |
FTD / Avg. Volume | 0.05% |
Short Selling Information
The latest short interest is 1.05M, so 0.73% of the outstanding
shares have been sold short.
Short Interest | 1.05M |
Short % of Shares Out | 0.73% |
Short % of Float | 1.15% |
Short Ratio (days to cover) | 2.4 |
Valuation Ratios
The PE ratio is -4.62 and the forward
PE ratio is -1.81.
Biodesix's PEG ratio is
0.1.
PE Ratio | -4.62 |
Forward PE | -1.81 |
PS Ratio | 2.78 |
Forward PS | 0.4 |
PB Ratio | 9.5 |
P/FCF Ratio | -3.82 |
PEG Ratio | 0.1 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Biodesix.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.76,
with a Debt / Equity ratio of 2.97.
Current Ratio | 2.76 |
Quick Ratio | 2.76 |
Debt / Equity | 2.97 |
Debt / EBITDA | -1.8 |
Debt / FCF | -1.19 |
Interest Coverage | -4.18 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $261,256.41 |
Profits Per Employee | $-157,256.41 |
Employee Count | 273 |
Asset Turnover | 0.73 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -74.34% in the
last 52 weeks. The beta is 1.17, so Biodesix's
price volatility has been higher than the market average.
Beta | 1.17 |
52-Week Price Change | -74.34% |
50-Day Moving Average | 0.56 |
200-Day Moving Average | 1.2 |
Relative Strength Index (RSI) | 46.42 |
Average Volume (20 Days) | 2,035,395 |
Income Statement
In the last 12 months, Biodesix had revenue of 71.32M
and earned -42.93M
in profits. Earnings per share was -0.33.
Revenue | 71.32M |
Gross Profit | 55.75M |
Operating Income | -34.5M |
Net Income | -42.93M |
EBITDA | -34.5M |
EBIT | -34.67M |
Earnings Per Share (EPS) | -0.33 |
Full Income Statement Balance Sheet
The company has 26.25M in cash and 61.98M in
debt, giving a net cash position of -35.73M.
Cash & Cash Equivalents | 26.25M |
Total Debt | 61.98M |
Net Cash | -35.73M |
Retained Earnings | -462.5M |
Total Assets | 86.24M |
Working Capital | 16.31M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -48.65M
and capital expenditures -3.23M, giving a free cash flow of -51.88M.
Operating Cash Flow | -48.65M |
Capital Expenditures | -3.23M |
Free Cash Flow | -51.88M |
FCF Per Share | -0.4 |
Full Cash Flow Statement Margins
Gross margin is 78.17%, with operating and profit margins of -48.37% and -60.19%.
Gross Margin | 78.17% |
Operating Margin | -48.37% |
Pretax Margin | -60.19% |
Profit Margin | -60.19% |
EBITDA Margin | -48.37% |
EBIT Margin | -48.37% |
FCF Margin | -72.74% |